GIBAC: A General Intermolecular Binding Affinity Calculator for Drug Discovery & Design - Benchmarking Databases

This article explores a comprehensive list of databases suitable for benchmarking GIBAC, a general intermolecular binding affinity calculator developed for computational drug discovery and design. GIBAC aims to revolutionize the process of drug discovery by providing a powerful tool for accurately predicting binding affinities between molecules. To ensure the robustness and reliability of GIBAC, thorough benchmarking against established datasets is crucial. This list highlights key databases that can be utilized for this purpose:

1. 'PDBbind': A comprehensive database housing experimentally measured binding affinities for protein-ligand complexes, offering a robust foundation for evaluating GIBAC's predictive capabilities.
2. 'DUD-E': This database provides benchmark sets of ligands specifically designed for virtual screening, allowing for a thorough assessment of GIBAC's performance in identifying potential drug candidates.
3. 'BindingDB': Another public database containing measured binding affinities for protein-ligand complexes, further enhancing the evaluation of GIBAC's accuracy.
4. 'ChEMBL': This extensive database encompasses bioactive molecules, including associated binding affinity data, providing a rich resource for evaluating GIBAC's predictive power across a broad spectrum of compounds.
5. 'DrugBank': A comprehensive database encompassing drugs, drug targets, and their interactions, offering valuable insights into GIBAC's ability to predict drug-target binding affinities.
6. 'CSAR': A benchmark dataset specifically designed for evaluating protein-ligand docking and scoring methods, allowing for a rigorous assessment of GIBAC's performance in this crucial aspect of drug discovery.
7. 'MUV': This dataset, specifically designed for evaluating virtual screening methods, provides a targeted platform for benchmarking GIBAC's ability to identify potential drug candidates from large libraries.
8. 'DUD': Another benchmark dataset specifically focused on evaluating virtual screening approaches, offering a complementary platform for assessing GIBAC's performance in this critical area.
9. 'Astex Diverse Set': This collection of protein-ligand complexes, chosen for their diversity, provides a valuable resource for evaluating GIBAC's performance across a wide range of molecular interactions.
10. 'PDBbind-CN': This database, focused on Chinese herbal medicines, offers a unique opportunity to benchmark GIBAC's predictive capabilities for a specific class of compounds.

The databases listed above provide a range of protein-ligand complexes and offer invaluable data for benchmarking GIBAC's performance in predicting binding affinities. By leveraging these resources, researchers can confidently assess GIBAC's capabilities and contribute to its development as a powerful tool for advancing drug discovery and design.